Roche, Spark push back takeover deadline in $4.3 billion deal
Swiss drugmaker Roche has agreed to extend the takeover deadline in its $4.3 billion bid for U.S. gene therapy specialist Spark Therapeutics , adding it remains “fully committed” to the transaction and expects it to...
Read More